Richard McCluney was diagnosed with Myeloma in 2016. Having directly benefited from the incredible new treatments that MMRF has helped get approved, he feels passionately about fundraising and raising awareness for the disease. Richard and his family have participated in the San Francisco 5K Team for Cures Walk/Run for the last 5 years, and as a keen cyclist, Richard feels that participating in the Road to Victories this year is too good an opportunity to pass up.
At Janssen Oncology, we’re shaping the future of cancer treatment. In the process, we’re striving to change expectations of what a cancer diagnosis means. Our purpose is driven by an urgency and commitment to bringing transformational cancer solutions to the people who need them. Passionate about our work, we are driven by the personal connection many of us share with the disease. With our partners, we focus on delivering solutions that make a positive impact on human health. We are part of Janssen Biotech, Inc., and the Janssen Pharmaceutical Companies of Johnson & Johnson.About Janssen Oncology
Click below to learn more about a treatment option for multiple myeloma. If you’re also interested in getting more information from Janssen, sign up for ongoing communications.Learn More